OrthoScan, Inc. manufactures the OrthoScan High Definition Mini C-Arm for extremity imaging. Designed for orthopedic surgeons, the small, lightweight C-arm configuration fluoroscopic system aims to provide real-time images with four times the resolution of other currently available fluoroscans. It can be used during surgical orthopedic procedures, and critical and emergency care procedures. OrthoScan, headquartered in Scottsdale, Arizona, uses state-of-the-art technologies to bring x-ray imaging in extremity surgery to a next level. For instance, innovative flat detectors in the latest product introduction named OrthoScan HD, allows reduction of distortions inherent with previous image intensifier technology, thereby improving significantly diagnostic accuracy. The mini C-Arms by OrthoScan provide the solution needed by orthopaedics and podiatrists for high-quality imaging in a small-scale device, facilitating complex surgeries on small and delicate body structures, such as wrists, knees and ankles. In September 2011, Orthoscan was acquired Aton, a German private investment firm. Orthoscan's valuation was not disclosed.
Expert Collections containing Orthoscan
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Orthoscan is included in 1 Expert Collection, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Orthoscan has filed 7 patents.
Radiography, Medical imaging, Spectroscopy, Radiology, Projectional radiography
Radiography, Medical imaging, Spectroscopy, Radiology, Projectional radiography
Latest Orthoscan News
Sep 11, 2023
Companies Covered ATON GmbH (Ziehm Imaging, Inc. and OrthoScan, Inc.), Canon Medical Systems Corporation, Eurocolumbus s.r.l., Shimadzu Corporation, Koninklijke Philips N.V., Siemens Healthineers AG, GE Healthcare, Hologic, Inc., and DMS Imaging. GE Healthcare Key Takeaways from the Market Study As of 2022, the coffee servers market was valued at US$ 2.0 billion By technology, the 2D imaging technology segment to enjoy high demand, accumulating a high revenue share during the forecast period. Based on product, the mobile C-arm segment is anticipated to dominate the industry during the forecast period Based on end-use, the hospitals and clinics segment is expected to generate high revenue during the forecast period, due to the increased demand in hospitals settings. C-arms Market: Key Trends and Opportunistic Frontiers The global X-ray sector is responding positively to the new and improved C-arm systems or machines, with an increase in the uptake of technologically advanced C-arms. The trend toward point-of-care imaging, where imaging is performed directly at the patient's bedside, has driven the demand for mobile C-arms. Continuous advancements in imaging technology have improved the capabilities of C-arms, leading to better image quality, higher resolution, and real-time imaging. These enhancements aid in precise diagnosis, treatment, and surgical planning, further boosting the demand for C-arms. The increasing technological advances and innovations, such as flat-panel detectors, digital imaging, 3D reconstruction, and dose reduction features, have improved the overall performance and safety of C-arms. These advancements attract healthcare providers looking to invest in state-of-the-art equipment. Unlock Insights and Make Informed Decisions – Purchase Our Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=74778<ype=S C-arms Market- Regional Analysis North America, is one of the largest markets for C-arms. Factors driving the market in this region include a well-established healthcare infrastructure, high healthcare expenditure, a significant number of medical facilities, and a demand for advanced imaging technologies. The market is characterized by a strong presence of leading manufacturers. The rapidly growing healthcare sector, increasing healthcare expenditure, and a large patient population contribute to the growth of the C-arms market in Asia Pacific. The growing demand for minimally invasive surgeries and interventional procedures, and increased healthcare spending in China and India drive the market demand. Competitive Landscape The global C-arms market is consolidated, with the presence of a small number of large players in the international markets and a few small players in regional markets. The top four to five players hold the majority share of the global C-arms market. Prominent players operating in the global C-arms market include ATON GmbH (Ziehm Imaging, Inc. and OrthoScan, Inc.) Canon Medical Systems Corporation Key Developments in the C-arm market Siemens Healthineers introduced the Artis icono family of C-arms, designed for interventional imaging. These systems incorporate advanced technologies, such as intelligent image processing and dose reduction features, to enhance image quality while minimizing radiation exposure. GE Healthcare has been focusing on innovation in C-arm technology, particularly in the field of mobile surgery. They have developed systems that offer improved mobility and ease of use for surgeons, helping to optimize workflow in the operating room. Philips Healthcare launched the Zenition family of mobile C-arms, designed for a wide range of surgical and interventional procedures. These systems aim to provide high image quality, ease of use, and efficient workflows. For Customization or Any Other Queries, Get in Touch with Our Industry Experts at: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=74778 C-arms Market – Key segments About Transparency Market Research Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports. Contact:
Orthoscan Frequently Asked Questions (FAQ)
When was Orthoscan founded?
Orthoscan was founded in 2002.
Where is Orthoscan's headquarters?
Orthoscan's headquarters is located at 8212 East Evans Road, Scottsdale.
What is Orthoscan's latest funding round?
Orthoscan's latest funding round is Loan.
How much did Orthoscan raise?
Orthoscan raised a total of $9.1M.
Who are the investors of Orthoscan?
Investors of Orthoscan include Paycheck Protection Program, Aton, California Technology Ventures, RC Capital and Aphelion Capital.
Who are Orthoscan's competitors?
Competitors of Orthoscan include EPIX Therapeutics, MAKO Surgical, Orthovita, IMRIS, Kjaya and 12 more.
Compare Orthoscan to Competitors
Nanocrystal Imaging Corporation (NIC) was founded in October 1997 to exploit some of NCT's discoveries in the creation of high quality digital x-ray images. This has been a major objective of the medical imaging industry during the last decade. Digital x-ray imaging systems developed to date by other manufacturers do not produce images with sufficiently high resolution and contrast. After a 4-year effort, NIC has developed patented products and processes which can provide a reliable platform to achieve high quality digital x-ray imaging. The first of NIC's products for commercial use is addressed to the dental imaging market, and will be marketed by mid 2003. Products addressing other market will be available in successive years. in the creation of nano-sized luminescent particles with light output equivalent to that of commercial phosphors 1000 times larger
Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.
Digital Surgery Systems provides digital 3D visualization and guidance for microsurgery. The company has developed a 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. It was formerly known as TrueVision Systems. The company was founded in 2003 and is based in Goleta, California.
MicroMRI has developed an method to visualize bone micro-architecture using high resolution MRI. MicroMRI's product is post-processing software that converts MRI images into three-dimensional display of bone microarchitecture with the possibility of manual or automated measurements. MicroMRI can also provide a dedicated coil for high-resolution MR imaging of the wrist. Clinical investigators have used MicroMRI's post-processing software in combination with a modified spin echo pulse sequence called FLASE (Fast Large Angle Spin Echo).
TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.